Delisting riskPopularity #4,622
Vaxart (VXRT)
Clinical-stage biotech developing oral tablet vaccines for infectious disease.
$0.4699
After hours−0.01 (−1.07%)
At close$0.4750(−1.06%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.31
Revenue estimate
$14.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.05−$0.07−$0.07−$0.04−$0.11$0.02−$0.06Pending
Estimate−$0.10−$0.07−$0.09−$0.07−$0.05$0.02−$0.12−$0.31
Surprise+50.0%0.0%+22.2%+42.9%−120.0%0.0%+50.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$15.2M$20.9M$39.7M$72.4M$104.2M$39.2M$27.2MPending
Estimate$20.8M$2.9M$2.2M$36.0M$69.7M$65.5M$26.2M$14.6M
Surprise−26.9%+632.5%+1,705.9%+101.4%+49.6%−40.1%+3.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | $0.18 | — | — |
| Nov 2026 | −$0.31 | — | — |
| Aug 2026 | −$0.12 | −$0.06 | +50.0% |
| May 2026 | $0.02 | $0.02 | 0.0% |
| Mar 2026 | −$0.05 | −$0.11 | −120.0% |
| Nov 2025 | −$0.07 | −$0.04 | +42.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | $0.18 | — | — | $13.5M | — | — | — |
| Nov 12, 2026 | −$0.31 | — | — | $14.6M | — | — | — |
| Aug 6, 2026 | −$0.12 | −$0.06 | +50.0% | $26.2M | $27.2M | +3.7% | −3.4% |
| May 7, 2026 | $0.02 | $0.02 | 0.0% | $65.5M | $39.2M | −40.1% | −5.4% |
| Mar 12, 2026 | −$0.05 | −$0.11 | −120.0% | $69.7M | $104.2M | +49.6% | −14.9% |
| Nov 13, 2025 | −$0.07 | −$0.04 | +42.9% | $36.0M | $72.4M | +101.4% | +10.8% |
| Aug 13, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 3, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 19, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 6, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 15, 2018 | |||||||
| Feb 6, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 31, 2017 | |||||||
| May 4, 2017 | |||||||
| Feb 2, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Sep 13, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 5, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Sep 11, 2015 |